Amyloid β protein deposition in normal aging has the same characteristics as that in Alzheimer's disease: Predominance of Aβ42(43) and association of Aβ40 with cored plaques

American Journal of Pathology

Volumn 148, Issue 1, 1996, Pages 259-265

  Fukumoto, Hiroaki ^a,b   Asami Odaka, Asano ^b   Suzuki, Nobuhiro ^b   Shimada, Hiroyuki ^c   Ihara, Yasuo ^a   Iwatsubo, Takeshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN CHEMISTRY; HUMANS; MIDDLE AGED;

EID: 0030064140     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Selkoe DJ: The molecular pathology of Alzheimer's disease Neuron 1991, 6:487-498
2. Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeachik K-H, Multhaup G, Beyreuther K, MüHer-Hill B The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature 1987, 325 733-736
3. Mann DMA Cerebral amyloidosis, aging and Alzheimer disease: a contribution from studies on Down's syndrome. Neurobiol Aging 1989, 10.397-399
4. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease Nature 1991, 349:704-706
5. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L. A pathogenetic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid Nature Genet 1992, 1.354-347
6. Joachim CL, Duffy LK, Morris JH, Selkoe DJ Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging. Brain Res 1988, 474:100-111
7. Mori H, Takio K, Ogawara M, Selkoe DJ: Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J Biol Chem 1992, 267.17082-17086
8. Roher AE, Lowenson JD, Clarke S, Wolkow C, Wang R, Cotter RJ, Reardon IM, Zürcher-Neely HA, Heinrikson RL, Ball MJ, Greenberg BD. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993, 268:3072-3083
9. Roher AE, Lowenson JD, Clarke S, Wood AS, Cotter RJ, Gowing E, Ball MJ. β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 1993, 90:10836-10840
10. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K: Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 1993, 301 41-52
11. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D: Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids Nature 1992, 359 325-327
12. Suzuki N, Cheung TT, Cai X-D, Odaka A, Otvos L Jr, Eckman C, Golde TE, Younkin SG: An increased percentage of long amyloid β protein is secreted by familial amyloid β protein precursor (β APP717) mutants Science 1994, 264:1336-1340
13. Jarrett JT, Berger EP, Lansbury PT Jr: The carboxyl terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease Biochemistry 1993, 32:4693-4697
14. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y: Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals, evidence that an initially deposited species is Aβ42(43) Neuron 1994, 13:45-53
15. Iwatsubo T, Mann DMA, Odaka A, Suzuki N, Ihara Y: Amyloid β-protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down's syndrome. Ann Neurol 1995, 37.294-299
16. Tomlinson BE, Blessed G, Roth M: Observations on the brains of non-demented old people J Neurol Sci 1968, 7.331-356
17. Mann DMA, Tucker CM, Yates, PO: The topographic distribution of senile plaques and neurofibrillary tangles in the brains of non-demented persons of different ages. Neuropathol Appl Neurobiol 1987, 13:123-139
18. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L Clinicopathologic studies in dementia nondemented subjects with pathologically confirmed Alzheimer's disease Neurology 1988, 38.1682-1687
19. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A Clinical, pathological, and neurochemical changes in dementia a subgroup with preserved mental status and numerous neocortical plaques Ann Neurol 1988, 23.138-144
20. Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992, 42:1681-1688
21. Hyman BT, Marzloff K, Arriagada PV: The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution J Neuropathol Exp Neurol 1993, 52.594-600
22. Jarrett JT, Lansbury PT Jr: Seeding "one-dimensional crystallization" of amyloid- a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993, 73:1055-1058
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34.939-944
24. Khachaturian ZS. Diagnosis of Alzheimer's disease Arch Neurol 1985, 42 1097-1104
25. Terry RD, Hansen LA, DeTeresa R, Davies P, Tobias H, Katzman R: Senile dementia of Alzheimer type without neocortical neurofibrillary tangles J Neuropathol Exp Neurol 1987, 46:262-268
26. Arai H, Lee VM-Y, Otvos L Jr, Greenberg B, Lowery DE, Sharma SK, Schmidt ML, Trojanowski J. Defined neurofilament, τ and β-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc Natl Acad Sci USA 1990, 87.2249-2253
27. Cras P, Kawai M, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci USA 1991, 88:7552-7556
28. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen S-H: Alzheimer's disease A double-labeling immunohistochemical study of senile plaques Am J Pathol 1988, 132:86-101
29. Barcikowska M, Wisniewski HM, Bancher C, Grundke-Iqbal I: About the presence of paired helical filaments in dystrophic neurites participating in the plaque formation. Acta Neuropathol 1989, 78.225-231
30. Shin R-W, Ogomori K, Kitamoto T, Tateishi J: Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease Am J Pathol 1989, 134.1365-1371
31. Hasegawa K. The clinical assessment of dementia in the aged a dementia screening scale for psychogeriatric patients. Aging in the Eighties and Beyond. Edited by M Bergener New York, Springer, 1983, 207-218
32. Imagawa M, Naruse S, Tsuji S, Fujioka A, Yamaguchi H: Coenzyme Q10, iron, and vitamin B6 in genetically-confirmed Aizheimer's disease Lancet 1992, 340.671
33. Suzuki N, Iwatsubo T, Odaka A, Ishibashi Y, Kitada C, Ihara Y High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 1994, 145:452-460
34. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 1987, 57:230-236
35. Ihara Y. Massive somatodendritic sprouting of cortical neurons in Aizheimer's disease Brain Res 1988, 459: 138-144
36. Tabaton M, Nunzi MG, Xue R, Usiak M, Autilio-Gambetti L, Gambetti P: Soluble amytoid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem Biophys Res Commun 1994, 200:598-603
37. Mann DMA, Younis N, Jones D, Stoddart RW: The time course of pathological events in Down's syndrome with particular reference to the involvement of microglial cells and deposits of β/A4. Neurodegeneration 1992, 1:201-215
38. Bugiani O, Tagliavini F, Giaccone G, Verga L, el-Hachimi K, Foncin J-F, Frangione B, Mann DMA, Davies CA: Diffuse senile plaques, amorphous or fibrous? Am J Pathol 1995, 146:777-779
39. Fukumoto H, Asami-Odaka A, Suzuki N, Iwatsubo T: Association of Aβ40-positive senile plaques with microglial cells in the brains of patients with Aizheimer's disease and in non-demented aged individuals Neurodegeneration (in press)
40. Mann DMA, Iwatsubo T, Fukumoto H, Ihara Y, Odaka A, Suzuki N: Microglial cells and amyloid β protein (Aβ) deposition, association with Aβ40 containing plaques. Acta Neuropathol 1995;90:472-477
41. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K: Apolipoprotein E immunoreactivity in cerebral amyloid deposits, and neurofibrillary tangles in Aizheimer's disease, and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991, 541:163-166